Polyethylene Glycol Electrolyte Lavage Solution versus Colonic Hydrotherapy for Bowel Preparation before Colonoscopy: A Single Center, Randomized, and Controlled Study

Table 1

Baseline characteristics of patients (𝑛=196).

	PEG-EL; (𝑛=102)	CHT; (𝑛=94)	𝑃
Age (years)	47.52±12.12	46.90±10.95	0.71
Range	20–78	18–68
Sex			0.919
Male	55 (53.9%)	50 (53.2%)
Female	47 (46.1%)	44 (46.8%)
BMI	22.14±2.22	22.72±3.20	0.145
Astriction condition	24 (23.53%)	32 (32.98%)	0.141
Previous colonoscopy experience			0.182
None	88 (86.3%)	72 (76.6%)
PEG-EL	13 (12.7%)	19 (20.2%)
CHT	1 (0.9%)	3 (3.2%)
Consumption of tobacco			0.518
0 (no smoking)	78 (76.5%)	72 (76.6%)
1 (<20 cigarettes/day)	16 (15.7%)	11 (11.7%)
2 (≥20 cigarettes/day)	8 (7.8%)	11 (11.7%)
Consumption of alcohol			0.419
1 (alcohol < 50 g/day)	99 (97.1%)	88 (93.6%)
2 (alcohol ≥ 50 g/day)	3 (2.9%)	6 (6.4%)
Reasons for Colonoscopy			0.301
Screening	24 (23.5%)	23 (24.5%)
Anemia	0 (0.0%)	1 (1.1%)
Hematochezia	2 (2.0%)	0 (0.0%)
Body weight loss	2 (2.0%)	6 (6.4%)
Abdominal pain or discomfort	37 (36.3%)	36 (38.3%)
Constipation	6 (5.9%)	7 (7.4%)
Diarrhea	12 (11.8%)	8 (8.5%)
Change in bowel habits	13 (12.7%)	12 (12.8%)
Follow-up after polyp or polypectomy	1 (1.0%)	1 (1.1%)
Follow-up for inflammatory bowel disease	5 (4.9%)	0 (0.0%)

Data are presented as the mean ± SD or 𝑛 (%).